USA/Korea look set to resume FTA talks
According to a report in the Korea Herald, the two-day meeting between South Korea and representatives from the USA on the subject of pharmaceuticals and medical equipment ended positively on August 29, and would allow both countries to restart stalled free trade agreement talks. Previously, the second round of the formal FTA talks, held in the South Korean capital Seoul, had ended prematurely due to disagreements regarding South Korea's new drug pricing policy (Marketletter July 24).
The South Korean Ministry of Health and Welfare said: "the US representatives agreed to accept the Korean government's positive-list drug-pricing policy and its plans to enforce it within the year." The Minister added that both sides had used the meeting to clarify their positions and better understand what each wanted out of the FTA.
Debate over FTA still rages in Korea
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze